about
Proteomic profiling in multiple sclerosis clinical courses reveals potential biomarkers of neurodegenerationOPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypesAxonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.A putative Alzheimer's disease risk allele in PCK1 influences brain atrophy in multiple sclerosis.Identification and clinical impact of multiple sclerosis cortical lesions as assessed by routine 3T MR imaging.The BDNF Val66Met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls.Meta-Analysis of Differential Connectivity in Gene Co-Expression Networks in Multiple Sclerosis.Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.Brain-derived neurotrophic factor and risk for primary adult-onset cranial-cervical dystonia.Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans.Prospective study of multiple sclerosis with early onset.Treating epilepsy in Italy between XIX and XX century.Genome-wide association study in musician's dystonia: a risk variant at the arylsulfatase G locus?CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers.A novel mutation (Thr116Ile) in the presenilin 1 gene in a patient with early-onset Alzheimer's disease.Molecular Characterization of Peripheral Extracellular Vesicles in Clinically Isolated Syndrome: Preliminary Suggestions from a Pilot Study.CADASIL: extended polymorphisms and mutational analysis of the NOTCH3 gene.Impact of catechol-O-methyltransferase Val(108/158) Met genotype on hippocampal and prefrontal gray matter volume.Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease.Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy.Apolipoprotein E genotype does not influence the progression of multiple sclerosis.HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe.Association between Synapsin III gene promoter polymorphisms and multiple sclerosis.The role of VLA4 polymorphisms in multiple sclerosis: an association study.Fas antigen and sporadic Alzheimer's disease in Southern Italy: evaluation of two polymorphisms in the TNFRSF6 gene.First mutation in the nuclear localization signal sequence of spastin protein identified in a patient with hereditary spastic paraplegia.Disease modeling in multiple sclerosis: assessment and quantification of sources of variability in brain parenchymal fraction measurements.The effects of BDNF Val66Met polymorphism on brain function in controls and patients with multiple sclerosis: an imaging genetic study.Neurofunctional correlates of personality traits in relapsing-remitting multiple sclerosis: an fMRI study.Investigating the role of brain-derived neurotrophic factor in relapsing-remitting multiple sclerosis.Adaptive cortical changes and the functional correlates of visuo-motor integration in relapsing-remitting multiple sclerosis.Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis.High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques.Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis.Prognostic significance of metabolic changes detected by proton magnetic resonance spectroscopy in ischaemic stroke.CAV3 T78M mutation as polymorphic variant in South Italy.A phenotypic variation of dominant optic atrophy and deafness (ADOAD) due to a novel OPA1 mutation.Comparison of clinical and demographic features between affected pairs of Italian multiple sclerosis multiplex families; relation to tumour necrosis factor genomic polymorphisms.Presenilin enhancer-2 gene: identification of a novel promoter mutation in a patient with early-onset familial Alzheimer's disease.Preliminary evidences of a NOS2A protective effect from relapsing-remitting multiple sclerosis.
P50
Q21131975-129AF1D4-B69E-4FD7-9655-220121E1C881Q24304868-67DDEC55-7D78-4C1D-ADE0-B8E1CA02B222Q31800788-67E0B652-5DDA-4CDB-83EA-08E91E4DFD22Q33769940-7071A2C4-7178-4684-84F5-355E10D6DADBQ33817835-B88B8D1A-38D2-4425-BBDB-3EE3A8D90DAAQ34674567-FA52387C-E7C9-4875-BD29-314C6710C156Q37050779-F9B33CD5-4195-468C-86E2-7743A00F5C82Q40431316-C3301C0E-90D7-400E-BE3C-23798F743126Q42622485-0EF4B7CE-9E50-4AE0-BD27-05CB47670537Q43945155-3BF92728-D92C-43E9-95E9-B07288311332Q43980182-7E2E4F57-A105-43A6-AA95-A8CB5071080DQ44024461-FEFC9FFE-35BF-4F8A-889E-21889C1596D1Q44248875-73395DDE-AA4E-4572-B05E-0CADE1D383A0Q44514324-4F58802C-F0FB-40C4-ADB0-CE3C35C9663EQ44992349-ABED3408-F3D1-4621-B5AE-AE06E52FACDBQ45905310-90238D80-6CB4-48CB-85D6-36602C138936Q46249496-C3A968BD-DA37-4F07-BB68-AB6D97614B9FQ46743546-49B596C1-8F71-454C-B05E-751D777FA611Q47395782-0531F2EA-EC5E-40AA-9765-5988CF8DC9B7Q47419398-EA88B9AA-1BF4-4C32-A942-89783CDF5F2EQ47611288-43FB9C02-1ECA-4DEA-BA4D-D46BDA098FB3Q47774655-9458CB95-9C20-41C8-B4C3-1A5FE2E9415CQ48021694-6987E12F-8C33-4C03-A30A-A451FC87B1F3Q48117489-A75616B6-D6F9-40E1-963D-0E9CDE207A53Q48218396-B39EB310-44C9-4466-A79C-52D7CE164EB7Q48230478-B12A9D13-CAC1-4D24-9308-0C1E328C4F28Q48250087-59939E5D-B12C-47F2-9F81-48341D90F7DBQ48421561-F4BCEE96-C7AE-416C-9E71-6231A2504A26Q48478921-84AD229E-523B-4404-8CE4-4F13AA92059AQ48514244-15C16FCF-7A25-4881-AC41-77775B3BE816Q48528227-4F13FA58-BB46-4B0F-97BD-068ABBAB6376Q48629641-38F2660D-16B0-4758-AE8B-4E4028ACFCDDQ48844459-F76332D0-8F55-42A4-889B-BB879FA3E7EFQ48887309-F0A28F7D-A241-4255-85B5-90FD8326ABB4Q49068701-71CC1F49-9775-4891-BAFF-CDA26AF9722BQ49192913-AC4E1235-D68E-4DED-84A7-532115D55405Q50453666-E4F2F8E2-2A0E-428B-AD00-D88E25954623Q52911420-857D8C70-21D6-430B-961F-559840ECD4B6Q53430740-01F592F5-C9AB-49B1-8E95-7DF487F3BC2CQ53770204-6D7E88F3-7172-4C9A-9876-84242AF21473
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria Liguori
@ast
Maria Liguori
@en
Maria Liguori
@es
Maria Liguori
@nl
Maria Liguori
@sl
type
label
Maria Liguori
@ast
Maria Liguori
@en
Maria Liguori
@es
Maria Liguori
@nl
Maria Liguori
@sl
altLabel
Maria Liguori
@en
prefLabel
Maria Liguori
@ast
Maria Liguori
@en
Maria Liguori
@es
Maria Liguori
@nl
Maria Liguori
@sl
P1053
D-4390-2016
P106
P1153
55531361400
P2038
Maria_Liguori
P21
P31
P3829
P496
0000-0003-4338-0392